scholarly journals Dietary Flavonoid Intake, Black Tea Consumption, and Risk of Overall and Advanced Stage Prostate Cancer

2013 ◽  
Vol 177 (12) ◽  
pp. 1388-1398 ◽  
Author(s):  
M. S. Geybels ◽  
B. A. J. Verhage ◽  
I. C. W. Arts ◽  
F. J. van Schooten ◽  
R. A. Goldbohm ◽  
...  
Author(s):  
Milan S. Geybels ◽  
Bas A.J. Verhage ◽  
Frederik J. van Schooten ◽  
Piet A. van den Brandt

2006 ◽  
Vol 9 (8) ◽  
pp. 1045-1054 ◽  
Author(s):  
Lidwine Johannot ◽  
Shawn M Somerset

AbstractObjectiveTo estimate flavonoid intake in the Australian population.DesignFlavonoid consumption was estimated from 24-hour recall data and apparent consumption data using US Department of Agriculture flavonoid composition data.SubjectsThe National Nutrition Survey 1995 assessed dietary intake (24-hour recall) in a representative sample (n = 13 858) of the Australian population aged 2 years and over.ResultsAnalysis of the 24-hour recall data indicated an average adult intake (>18 years) of 454 mg day− 1 (92% being flavan-3-ols). Apple was the highest quercetin source until age 16–18 years, after which onion became an increasingly important prominent source. Variations in hesperetin consumption reflected orange intake. Apple, apricot and grapes were the major sources of epicatechin and catechin for children, but subsided as wine consumption increased in adulthood. Wine was the main source of malvidin. Naringenin intake remained static as a percentage of total flavonoid intake until age 19–24 years, corresponding to orange intake, and then increased with age from 19–24 years, corresponding to grapefruit intake. Apparent dietary flavonoid consumption was 351 mg person− 1 day− 1, of which 75% were flavan-3-ols. Black tea was the major flavonoid source (predominantly flavan-3-ols) representing 70% of total intake. Hesperetin and naringenin were the next most highly consumed flavonoids, reflecting orange intake. Both 24-hour recall and apparent consumption data indicated that apigenin intake was markedly higher in Australia than reported in either the USA or Denmark, presumably due to differences in consumption data for leaf and stalk vegetables and parsley.ConclusionsTea was the major dietary flavonoid source in Australia. Flavonoid consumption profiles and flavonoid sources varied according to age. More consistent methodologies, survey tools validated for specific flavonoid intakes and enhanced local flavonoid content data for foods would facilitate better international comparisons of flavonoid intake.


2011 ◽  
Vol 63 (5) ◽  
pp. 663-672 ◽  
Author(s):  
Jusheng Zheng ◽  
Bin Yang ◽  
Tao Huang ◽  
Yinghua Yu ◽  
Jing Yang ◽  
...  

2013 ◽  
Vol 23 (3) ◽  
pp. 157-160 ◽  
Author(s):  
Susanna C. Larsson ◽  
Jarmo Virtamo ◽  
Alicja Wolk
Keyword(s):  

2021 ◽  
Vol 147 (2) ◽  
pp. AB49
Author(s):  
Michelle El-Hosni ◽  
Ariangela Kozik ◽  
Molly Cook ◽  
Research Lab Tech ◽  
Alan Baptist ◽  
...  

2013 ◽  
Vol 111 (8) ◽  
pp. 1421-1429 ◽  
Author(s):  
Deqing Yi ◽  
Xuerui Tan ◽  
Zhiguo Zhao ◽  
Yingmu Cai ◽  
Yiming Li ◽  
...  

Experimental studies have suggested that tea consumption could lower the risk of dyslipidaemia. However, epidemiological evidence is limited, especially in southern China, where oolong tea is the most widely consumed beverage. We conducted a population-based case–control study to evaluate the association between consumption of tea, especially oolong tea, and risk of dyslipidaemia in Shantou, southern China, from 2010 to 2011. Information on tea consumption, lifestyle characteristics and food consumption frequency of 1651 patients with newly diagnosed dyslipidaemia and 1390 controls was obtained using a semi-quantitative questionnaire. Anthropometric variables and serum biochemical indices were determined. Drinking more than 600 ml (2 paos) of green, oolong or black tea daily was found to be associated with the lowest odds of dyslipidaemia risk (P< 0·001) when compared with non-consumption, but only oolong tea consumption was found to be associated with low HDL-cholesterol levels. A dose–response relationship between duration of tea consumption and risk of dyslipidaemia (OR 0·10, 95 % CI 0·06, 0·16), as well as that between amount of dried tea leaves brewed and risk of dyslipidaemia (OR 0·34, 95 % CI 0·24, 0·48), was found. Moreover, consumption of oolong tea for the longest duration was found to be associated with 3·22, 11·99 and 6·69 % lower blood total cholesterol, TAG and LDL-cholesterol levels, respectively. In conclusion, the present study indicates that long-term oolong tea consumption may be associated with a lower risk of dyslipidaemia in the population of Shantou in southern China.


2016 ◽  
Vol 104 (3) ◽  
pp. 704-714 ◽  
Author(s):  
Shun-Chiao Chang ◽  
Aedin Cassidy ◽  
Walter C Willett ◽  
Eric B Rimm ◽  
Eilis J O’Reilly ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document